Advisory Services Network, LLC Janux Therapeutics, Inc. Put Options Transaction History
Advisory Services Network, LLC
- $4.9 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding JANX
# of Institutions
181Shares Held
40.3MCall Options Held
115KPut Options Held
681K-
Ra Capital Management, L.P. Boston, MA9.17MShares$337 Million5.81% of portfolio
-
Janus Henderson Group PLC London, X02.52MShares$92.8 Million0.06% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.4MShares$88.3 Million3.93% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$86.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.14MShares$78.6 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.53B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...